neurological disorders

Management and long-term haematological and neurological outcomes of Immunoglobulin M and Waldenström’s macroglobulinaemia-related neuropathy: A single-centre experience

Background and Rationale Immunoglobulin M (IgM) and Waldenström’s macroglobulinaemia (WM) have emerged as significant clinical entities, particularly in relation to

Management and long-term haematological and neurological outcomes of Immunoglobulin M and Waldenström’s macroglobulinaemia-related neuropathy: A single-centre experience Read Post »

Acute Motor Axonal Neuropathy (AMAN) Variant of Guillain-Barré Syndrome Following Influenza Vaccination as the Initial Presentation of Systemic Lupus Erythematosus With Lupus Nephritis

Background on Acute Motor Axonal Neuropathy Acute Motor Axonal Neuropathy (AMAN) is a subtype of Guillain-Barré syndrome (GBS), characterized by

Acute Motor Axonal Neuropathy (AMAN) Variant of Guillain-Barré Syndrome Following Influenza Vaccination as the Initial Presentation of Systemic Lupus Erythematosus With Lupus Nephritis Read Post »

Acute Motor Axonal Neuropathy (AMAN) Variant of Guillain-Barré Syndrome Following Influenza Vaccination as the Initial Presentation of Systemic Lupus Erythematosus With Lupus Nephritis

Overview of AMAN and Guillain-Barré Syndrome Acute Motor Axonal Neuropathy (AMAN) is a subtype of Guillain-Barré Syndrome (GBS), which primarily

Acute Motor Axonal Neuropathy (AMAN) Variant of Guillain-Barré Syndrome Following Influenza Vaccination as the Initial Presentation of Systemic Lupus Erythematosus With Lupus Nephritis Read Post »

Scroll to Top